The U.S. Food and Drug Administration (FDA) Commissioner has again reiterated that the FDA do not consider CBD safe enough to be sold as a dietary supplement. Last year in the UK, the Food Standards Agency reduced the recommended daily dose of CBD from 70mg to 10mg.

This

In this week's highlights from companies on the Aquis Stock Exchange: Marula Mining | AQSE: MARU | #MARU, Shepherd Neame , Ananda Developments Plc, Rogue Baron Shinju Japanese Whisky, KR1 plc, Aquis Exchange & Supernova Digital Assets

Last week Ananda announced the establishment of our Scientific Advisory Board, explained here by Finance Director J. Sturgess-Smith.

To subscribe for more updates like this please visit our investor hub at investors.anandadevelopments.com/s/04261b.

Ananda Developments - Establishment of Scientific Advisory Board #ANA Ananda Developments Plc voxmarkets.co.uk/rns/announceme…

Ananda is pleased to announce the establishment of its Scientific Advisory Board (SAB). The SAB brings a wealth of experience across successful pharmaceutical, biotechnology and healthcare companies and will be Chaired by Ananda non-executive director Professor Clive Page OBE.

We are all set for tomorrow's #masterinvestorshow at the Business Design Centre in London. Come and see us at booth M19!

Industry news show with Katya Kowalski for Volteface

We discuss:

CB1 Medical admin fee drama 01:00
Medisonal makes it 43 clinics in the UK 06:28
Script Assist 'Find a Dr' launches 10:34
Ananda Developments Plc announce new trial 14:30
Curaleaf Clinic GROW® Group : media watch

A reminder to those not already signed up that Ananda will be at the #masterinvestorshow tomorrow. Follow the link below and book your free ticket using the code ANANDA. We look forward to seeing you there!

Thanks Business of Cannabis | Europe for the coverage.

Visit our Hub to read the full announcement: investors.anandadevelopments.com/s/f3e10b.

RNS Hotlist February 28: Adriatic, Ananda, Artemis, Bradda, Cykel, 88 Energy, EnSilica, EDX Medical, Good Life, Image Scan, Redx, Trellus, Vinanz - Zaks Traders Cafe zakstraderscafe.com/rns-hotlist-fe… #ADT1 #ANA #ARV #BHL #CYK #88E #ENSI #EDX #GDLF #IGE #REDX #TRLS #Vinanz

Ananda's Finance Director J. Sturgess-Smith provides an update to shareholders on the signing of the drug supply agreement for ENDOCAN-1: A Pilot Randomised Controlled Trial of the Efficacy of a Cannabinoid Oral Tincture in the Management of Endometriosis-Associated Pain.

We are pleased to announce our subsidiary MRX Medical has signed the drug supply agreement with Edinburgh University and #NHS Lothian for the provision of its MRX1 cannabidiol oil to the ENDOCAN-1 RCT into the use of CBD to treat endometriosis-related pain.

investors.anandadevelopments.com/s/f3e10b

We are very excited to speak to investors at Master Investor show in London on 9 March. Follow the link below and use the code ANANDA for your free ticket, or get in touch with us via our investor hub at investors.anandadevelopments.com/s/04261b

We've just released the following announcement: Ananda is presenting at Master Investor!

Check out the full announcement and join in with the conversation at: investors.anandadevelopments.com/announcements/…

#ANA

This morning Ananda released its Quarterly Trading Statement for the quarter ended 31 January 2024.

Read the full statement here: investors.anandadevelopments.com/s/f3e10b

Ananda subsidiary, MRX Medical, has just published an MRX Medical News story titled 'Cannabidiol (CBD) and the treatment of chronic pain'. This article assesses challenges with treating chronic pain and the potential of CBD.

Read the full article here: mrxmedical.com/post/cbd-and-t…

Are you interested in Ananda and our mission to be a leading provider of cannabinoid medicines for complex, chronic inflammatory pain conditions?

Sign up to our investor hub for regular updates, videos, announcements and more: investors.anandadevelopments.com/s/04261b

Thanks to Proactive for hosting Ananda Finance Director J. Sturgess-Smith at the Proactive One2One Investor Forum.

Watch Jeremy's full presentation here: proactiveinvestors.co.uk/companies/news…